Title of article
miR-146a rs2910164 polymorphism and lung cancer in a Tehran population
Author/Authors
JAHANGIR SOOLTANI ، Niloofar Department of Medical Biotechnology Biotechnology - National Institute of Genetic Engineering and Biotechnology , Pakzad ، Hossein Department of biology - Islamic azad university, Tehran-east branch , Saremi ، Mohammad Ali Personalized Medicine Research Center of AmitisGen
From page
10
To page
13
Abstract
Lung cancer is still the most common cancer worldwide in terms of the number of newly diagnosed cases and mortality rate. The expression of miR-146a was reduced in mesenchymal-like lung cancer cell lines. The overexpression of miR-146a induced a marked reduction of the mesenchymal marker and increase in the epithelial marker in lung cancer cell lines. The current study investigated the association of miR-146a genotypes and lung susceptibility in a Tehran population to determine the visibility of using RFLP-PCR genotype. The results revealed a significantly higher frequency of miR-146a CG and CC genotypes (p =0.01 and p=0.008, respectively) in patients compared with the control group. Those with the miR-146a GC and CC genotypes had an increased risk for developing lung cancer (OR=1.9; 95% CI: 1.1-3.3 and OR=4.1; 95% CI: 1.5-12.3, respectively). Moreover, the frequency rates of miR-146a CC genotype and C allele were significantly higher in patients than in the controls (p =0.006 and p=0.000, respectively).
Keywords
Lung cancer , MicroRNA , RFLP , PCR genotype , epithelial , mesenchymal transition
Journal title
Personalized Medicine Journal
Journal title
Personalized Medicine Journal
Record number
2743041
Link To Document